Open AccessThis article is
- freely available
Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction
Department of Infectious Disease, King’s College London School of Medicine, Guy’s Hospital, London SE1 9RT, UK
These authors contributed equally to this manuscript.
* Author to whom correspondence should be addressed.
Received: 18 March 2011; in revised form: 19 April 2011 / Accepted: 28 April 2011 / Published: 6 May 2011
Abstract: Tetherin (BST2/CD317) has been recently recognized as a potent interferon-induced antiviral molecule that inhibits the release of diverse mammalian enveloped virus particles from infected cells. By targeting an immutable structure common to all these viruses, the virion membrane, evasion of this antiviral mechanism has necessitated the development of specific countermeasures that directly inhibit tetherin activity. Here we review our current understanding of the molecular basis of tetherin’s mode of action, the viral countermeasures that antagonize it, and how virus/tetherin interactions may affect viral transmission and pathogenicity.
Keywords: Tetherin/BST2; restriction of enveloped virus release; interferon; viral countermeasure; Vpu
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Le Tortorec, A.; Willey, S.; Neil, S.J.D. Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction. Viruses 2011, 3, 520-540.
Le Tortorec A, Willey S, Neil SJD. Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction. Viruses. 2011; 3(5):520-540.
Le Tortorec, Anna; Willey, Suzanne; Neil, Stuart J. D. 2011. "Antiviral Inhibition of Enveloped Virus Release by Tetherin/BST-2: Action and Counteraction." Viruses 3, no. 5: 520-540.